Vantage Point: Investing for Alpha  

Why the hunt for outliers remains compelling

James Budden

Over the past year or so we have seen a rally in value against growth.

The long, slow outperformance of growth that had been evident since mid-2007, and that had exploded upwards in 2020, reversed significantly.

Growth, as defined by MSCI indices, underperformed value by 19 per cent in the 18 months to end July 2022. Those at the high growth end of the spectrum saw considerably worse declines in that 18-month period.

Article continues after advert

Was this foreseeable? Some would argue that it was, as inflation was taking hold even before the Russian invasion of Ukraine.

The standard policy response to higher inflation is higher interest rates, which in conventional wisdom reduces the present value of the future profits of companies, raises the cost of borrowing for those who are leveraged, and makes it harder for early-stage companies to raise finance.

So, markets have reacted pretty much as we would have expected, with the magnitude of the growth correction most severe for those companies with the most future-dependent profitability.

How to make sense of it all

What are we to make of this? Is it that growth will only recover when markets start to anticipate lower inflation and lower interest rates?

To some extent this is probably true and we may have seen the beginnings of it as recession looms over further interest rate increases. But here’s the thing – at least at Baillie Gifford – we don’t think any of this actually matters very much.

All growth is not equal. Some growth companies are indebted, some aren’t. Some have entrenched competitive advantages and therefore pricing power, some don’t.

Some are creating whole new business models and products, others are locked in a fierce battle to undercut their competitors in the face of rising costs.

Some earlier stage companies are well-funded and have a path to profitability, some have flaky business models and in a different funding environment would never have got off the ground.

Some are cashflow positive, some continue to be reliant on now harder-to-secure external funding.

Myopic

On the value side, some companies are cheap because investors have become hugely myopic and risk-averse. Quite a few growth stocks have become value stocks in the past 18 months, without any real change in their operational prospects.

Some other ‘value’ companies are cheap because they are in irreversible decline as their business models or products are replaced by newer, better ones.  

Thinking about growth and value as opposing forces therefore isn’t very helpful. Really what we are talking about is differing investment horizons and approaches to investing.

Simplistically, value is about buying companies that are currently under-appreciated by the market relative to their tangible value or earnings.

Growth (at least to us) is about buying companies that are secularly under-appreciated by the market relative to their future earnings. No one’s actually trying to invest in the opposite of a value stock, are they?